Simulations Plus, Inc.

American Association of Pharmaceutical Scientists (AAPS) #pharmsci360 #RAPIDFIRE alert - Join Kyunghee Yang "Model Informed Drug Development: 2020 and Beyond" today at 3:30 ET. #DILIsym #software has been used to evaluate dozens of compounds, supporting internal decision-making as well as regulatory discussions. bit.ly/34xhpsc

Attending this year’s American Association of Pharmaceutical Scientists (AAPS) #pharmsci360? Today’s opening day and we can’t wait to see you at our virtual booth VB1921! Arlene Padron, Daniel J. O'Connor, Sr., Cherylann Iagatta will be your hosts. In the meantime, check out the posters and presentations in store: https://bit.ly/34xhpsc

The #MonolixSuite 2020 release is just around the corner! Get familiar with the NEW features here: https://youtu.be/-jyIJiczKbs #MBDD #modelingandsimulation #software for #DrugDevelopment

We’re #hiring! We have an immediate #opening for a #Scientist II who will make significant contributions to the model development and validation business line. This position is for Lancaster, CA, though remote options will be considered. Apply here: https://bit.ly/2H9yuzT #PBPKmodeler #careers #nowhiring

#DILIsym utilizes various data types to inform decisions learn how here: https://youtu.be/34mYOdIHtBo #QSTmodeling #PBPKmodeling #DILI #clinicaldata #modelingandsimulation

Learn how #ADMETPredictor was used in the UofA’s dept of pharm & pharmsci #phytocannabinoid metabolic research. Relax and rewind the #webinar with Daniela Amaral Silva, Raimar Löbenberg, and Bob Clark. https://youtu.be/BD8P3rxvbjA

#GastroPlus Version 9.8 is modeling more than just the gut! NEW intraarticular injection model, enhancements to the #dermal, #ocular, #oral dosage routes. Save your spot here: https://bit.ly/3dxJTF8

"It is recommended that appropriately verified mechanistic #PBPK modeling can be leveraged with high to moderate confidence as a key approach to predicting potential food effect..." Read more here: https://bit.ly/35gTWen #GastroPlus

Simulations Plus is happy to announce that through a joint proposal with the University of Health Sciences and Pharmacy in St. Louis, it has been awarded a new funded cooperative agreement from the U.S. Food and Drug Administration #FDA to establish novel in vitro/in silico models for the oral cavity route of administration in #GastroPlus to accelerate #pharmaceutical research and #regulatory assessment of innovative and generic drug products delivered intraorally. https://bit.ly/2IifUFJ

Paul Watkins DILIsym Services, a Simulations Plus Company to present at Global Antibiotic R&D Partnership (GARDP) #REVIVE #webinar Oct.8. Exploring safety issues in antimicrobial drug development. Register here: https://lnkd.in/gYgk7EJ

#TrendingTopic: Application of #ADMETPredictor to #phytocannabinoids metabolic pathways. Join the Oct. 8 #webinar with Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta & Bob Clark to learn more: https://bit.ly/30kJsZD

Maxime Le Merdy to present at 2020 GMP Symposium on Oct. 9. FREE #webinar registration to learn about PK challenges in #pediatric development. #GastroPlus #PBPKmodeling Register here: https://bit.ly/30RhogT

Find out how quantitative systems toxicology #QST can be used to explore #safety issues in #antibiotic development with Paul Watkins. Register here: https://lnkd.in/g8KH34t